Hasan Jafri - Oct 4, 2021 Form 4 Insider Report for Aridis Pharmaceuticals, Inc. (ARDS)

Role
Chief Medical Officer
Signature
/s/ Hasan Jafri
Stock symbol
ARDS
Transactions as of
Oct 4, 2021
Transactions value $
$0
Form type
4
Date filed
10/5/2021, 06:35 PM
Previous filing
Sep 8, 2021
Next filing
Dec 7, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARDS Stock Options Award $0 +30K +33.33% $0.00 120K Oct 4, 2021 Common Stock 30K $3.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options vest in equal installments over 48 months, beginning on October 4, 2021.